Medicare Enrolled
Dr. Aju Daniel, MD
Internal Medicine · Shrewsbury, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Daniel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Daniel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Daniel
Dr. Aju Daniel is an internal medicine specialist in Shrewsbury, MA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Daniel performed 2,772 Medicare services across 1,428 unique beneficiaries.
Between the years covered by Open Payments, Dr. Daniel received a total of $6,056 from 32 pharmaceutical and/or device companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Daniel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 7% volume in MA
$6,056 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,772
Medicare services
Top 7% in MA for internal medicine
1,428
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~163 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
661 | $63 | $230 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
283 | $96 | $350 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
255 | $95 | $370 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
215 | $8 | $17 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
186 | $8 | $29 |
| Liver function blood test panel | 182 | $8 | $28 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
173 | $8 | $26 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
141 | $104 | $432 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
136 | $140 | $470 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
121 | $139 | $638 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
83 | $3 | $11 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
53 | $13 | $50 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
28 | $16 | $58 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $59 | $250 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
28 | $79 | $270 |
| Annual depression screening | 28 | $19 | $58 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
27 | $132 | $400 |
| New patient office visit, complex (60-74 min) | 26 | $178 | $656 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
23 | $10 | $40 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
21 | $11 | $140 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
17 | $3 | $9 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
17 | $5 | $18 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
15 | $29 | $99 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
14 | $15 | $51 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
11 | $19 | $62 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,056
Total received (2018-2024)
Avg $865/year across 7 years
Top 15% in MA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
236
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,930 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$125 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$594
2023
$363
2022
$364
2021
$132
2020
$377
2019
$2,452
2018
$1,773
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$171
ABBVIE INC.
$158
Boehringer Ingelheim Pharmaceuticals, Inc.
$132
ViiV Healthcare Company
$62
Lilly USA, LLC
$48
Mylan Specialty L.P.
$22
Top 3 companies account for 77.8% of 2024 payments
All-time payments by company (2018-2024) ›
ViiV Healthcare Company
$832
Gilead Sciences, Inc.
$757
GlaxoSmithKline, LLC.
$487
Janssen Products, LP
$484
Boehringer Ingelheim Pharmaceuticals, Inc.
$444
Novo Nordisk Inc
$406
Merck Sharp & Dohme Corporation
$342
Janssen Pharmaceuticals, Inc
$241
AstraZeneca Pharmaceuticals LP
$224
Abbott Laboratories
$169
ABBVIE INC.
$158
Allergan Inc.
$158
Paratek Pharmaceuticals, Inc.
$154
Amarin Pharma Inc.
$145
Janssen Biotech, Inc.
$141
Lilly USA, LLC
$129
Mylan Specialty L.P.
$129
SANOFI-AVENTIS U.S. LLC
$110
Teva Pharmaceuticals USA, Inc.
$88
Melinta Therapeutics, Inc.
$80
Oxford Immunotec USA Inc
$75
Kowa Pharmaceuticals America, Inc.
$64
AbbVie, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$33
Alkermes, Inc.
$31
PFIZER INC.
$30
Sunovion Pharmaceuticals Inc.
$26
Supernus Pharmaceuticals, Inc.
$21
Theratechnologies Inc.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Shire North American Group Inc
$15
Napo Pharmaceuticals Inc
$13
Top 3 companies account for 34.3% of all-time payments
Associated products mentioned in payments ›
AJOVY · ANORO · ANORO ELLIPTA · APRETUDE · AVYCAZ · BASAGLAR · BEVESPI AEROSPHERE · BROVANA · BYDUREON · Baxdela · Biktarvy · CHANTIX · DALVANCE · DIFICID · DOVATO · Dymista · EGRIFTA · EMGALITY · FARXIGA · GATTEX · ISENTRESS · JANUVIA · JARDIANCE · JULUCA · LINZESS · Livalo · Mavyret · Mitra Clip system · Motegrity · Mytesi · NUZYRA · Ozempic · PNEUMOVAX 23 · PRALUENT · PREZCOBIX · Perforomist · QULIPTA · RUKOBIA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · SYMTUZA · Symtuza · TEFLARO · TRADJENTA · TRELEGY ELLIPTA · TRIUMEQ · TROKENDI XR · TRULICITY · Tresiba · UBRELVY · VIBERZI · Vascepa · Victoza · Vivitrol · XARELTO · XIFAXAN · YUPELRI · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
1,217
Per 100K population
141.2
County median income
$93,561
Nearest hospital
WORCESTER RECOVERY CENTER AND HOSPITAL
3.5 mi
3.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Daniel is a clinical cardiology specialist, with above-average Medicare volume (top 7% in MA), with low-engagement industry engagement in the top 15% of MA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Daniel experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Daniel performed 661 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Daniel receive payments from pharmaceutical companies?
Yes. Dr. Daniel received a total of $6,056 from 32 companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Daniel's costs compare to other internal medicine physicians in Shrewsbury?
Dr. Daniel's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Daniel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Shrewsbury
Browse internal medicine physicians in Shrewsbury ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MA
Which MA internal medicine physicians receive the most from drug and device companies.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology